Author:
Raghavan D,Zalcberg J R,Grygiel J J,Teriana N,Cox K M,McCarthy W,Flynn M
Abstract
PURPOSE This study assessed whether a specific association exists between atypical nevi and germ cell tumors (GCT). METHODS A prospective comparison was performed on a cohort of 129 unselected patients with GCT and a series of 153 healthy men. Three or more of the following criteria were required for diagnosis of multiple atypical nevi: greater than 5 mm in diameter; variegated color, often speckled black/brown, with irregularly distributed pigmentation; irregular outline or indistinct border; and at least three such lesions. RESULTS Prevalences for multiple atypical nevi in patients with GCT and in healthy controls were 37% and 15%, respectively (P < .01). Two patients with these lesions also had documented malignant melanoma. In contrast, 16% of patients with GCT had a history of testicular maldescent (the most common known risk factor), compared with 5% of healthy controls (P < .01). CONCLUSION Multiple atypical nevi occur with a statistically significant increased prevalence in patients with GCT as compared with healthy controls, and constitute one of the most common known clinical associations with this malignancy. These data may be of relevance for our understanding of the biology of GCT and of malignant melanoma, in the design of screening programs for testis cancer, and in the follow-up evaluation of patients with each of these disorders.
Publisher
American Society of Clinical Oncology (ASCO)
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Skin cancer risk among testicular germ‐cell cancer survivors: a systematic review and meta‐analysis;Journal of the European Academy of Dermatology and Venereology;2022-02-09
2. Testis Cancer;Holland-Frei Cancer Medicine;2017-02-26
3. Testicular Cancer;Cancer in Adolescents and Young Adults;2016-11-18
4. Cutaneous manifestations of genitourinary malignancy;Seminars in Oncology;2016-06
5. Germ Cell Tumors: Looking to the Future;American Society of Clinical Oncology Educational Book;2015-05